Electromed Dividends
| ELMD Stock | USD 24.85 0.59 2.43% |
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 35.18. Electromed's past performance could be the main factor of why investors trade Electromed stock today. Investors should clearly understand every aspect of the Electromed dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Electromed's dividend schedule and payout information. Electromed dividends can also provide a clue to the current valuation of Electromed.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 33.51 | 35.18 |
Electromed | Build AI portfolio with Electromed Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Electromed must own a stock before its ex-dividend date to receive its next dividend.
Electromed Dividends Paid Over Time
Today, most investors in Electromed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Electromed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Electromed dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Will Health Care Equipment & Supplies sector continue expanding? Could Electromed diversify its offerings? Factors like these will boost the valuation of Electromed. Projected growth potential of Electromed fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Electromed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.455 | Earnings Share 1.03 | Revenue Per Share | Quarterly Revenue Growth 0.163 | Return On Assets |
Electromed's market price often diverges from its book value, the accounting figure shown on Electromed's balance sheet. Smart investors calculate Electromed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Electromed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Electromed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Electromed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.